Effective Treatment of Indolent Non-Hodgkin’s Lymphomas with Mitoxantrone, Chlorambucil and Prednisone

Publisher： Karger

E-ISSN： 2296-5262|28|2|73-78

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.28, Iss.2, 2005-01, pp. : 73-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Multicenter Trial SAKK 37/95 of Cladribine, Cyclophosphamide and Prednisone in the Treatment of Chronic Lymphocytic Leukemias and Low-Grade Non-Hodgkin’s Lymphomas

By  

Acta Haematologica, Vol. 117, Iss. 1, 2006-11 ,pp. : 40-47

Karger

Access to resources Recommend Favorite

Biomarkers in childhood non-Hodgkin’s lymphomas

By Dokmanovic Lidija  

Biomarkers in Medicine, Vol. 7, Iss. 5, 2013-10 ,pp. : 791-801

Future Medicine

Access to resources Recommend Favorite

Acute Toxicity of Mitoxantrone, Chlorambucil and Prednisolone (MCP) versus MCP plus Rituximab in Low-Grade Non-Hodgkin’s Lymphoma – Interim Results of a Phase III Trial

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 164-166

Karger

Access to resources Recommend Favorite

Clinical Features and Treatment Outcomes of Non-Hodgkin’s Lymphomas Involving Rare Extranodal Sites: A Single-Center Experience

By  

Acta Haematologica, Vol. 123, Iss. 1, 2009-12 ,pp. : 48-54

Karger

Access to resources Recommend Favorite

Isolation of Side Population Cells in B-Cell Non-Hodgkin’s Lymphomas

By  

Acta Haematologica, Vol. 129, Iss. 1, 2012-09 ,pp. : 10-17

Karger

Access to resources Recommend Favorite